Table 4. LN metastasis signature score > 4 was more common in N1 vs. N0 patients (p=0.002) among the validation cohort of PDAC patients (n=54).
LN metastasis | |||||
---|---|---|---|---|---|
0 | 1 | Total | |||
LN metastasis signature | 0 | Count | 12 | 7 | 19 |
Score>4 | % within LN metastasis signature score>4 | 63.2% | 36.8% | 100% | |
1 | Count | 5 | 30 | 36 | |
% within LN metastasis signature score>4 | 14.3% | 85.7% | 100% | ||
Total | Count | 17 | 37 | 54 | |
% within LN metastasis signature score>4 | 31.5% | 68.5% | 100% |